Minerva Neurosciences to Report Third Quarter 2017 Financial Results and Business Updates on November 6, 2017
(Thomson Reuters ONE) -
Management to host conference call
WALTHAM, Mass., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc.
(NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the
development of therapies to treat central nervous system (CNS) disorders, today
announced that it will release financial results and business updates for the
third quarter of 2017 on Monday, November 6, 2017. The Company will host a
webcast and conference call that day at 8:30 a.m. Eastern Time to discuss these
results and updates.
The live call may be accessed by dialing (877) 312-5845 for domestic callers or
(765) 507-2618 for international callers and referring to conference ID number
90294475. A live webcast of the conference call will be available online in the
Investors and Media section of the Company's website at
ir.minervaneurosciences.com. The archived webcast will be available on the
Company's website beginning approximately two hours after the event for 30 days.
About Minerva Neurosciences
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company
focused on the development and commercialization of a portfolio of products to
treat CNS diseases. Minerva's proprietary compounds include: MIN-101, in
clinical development for schizophrenia; Seltorexant (MIN-202 or JNJ 42847922),
in clinical development for insomnia and major depressive disorder (MDD); MIN-
117, in clinical development for MDD; and MIN-301, in pre-clinical development
for Parkinson's disease. Minerva's common stock is listed on the NASDAQ Global
Market under the symbol "NERV." For more information, please
visit www.minervaneurosciences.com.
Contact:
William B. Boni
VP, Investor Relations/
Corp. Communications
Minerva Neurosciences, Inc.
(617) 600-7376
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Minerva Neurosciences, Inc. via GlobeNewswire
Datum: 30.10.2017 - 13:30 Uhr
Sprache: Deutsch
News-ID 565815
Anzahl Zeichen: 2414
contact information:
Town:
Waltham
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 256 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Minerva Neurosciences to Report Third Quarter 2017 Financial Results and Business Updates on November 6, 2017"
steht unter der journalistisch-redaktionellen Verantwortung von
Minerva Neurosciences, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
